CrushSCI.com
Journal Selection & Manuscript Polishing Services
Molecular Neurodegeneration journal cover Medicine
Back to journal directory

Review Cycle Records

Molecular Neurodegeneration

Springer SCIE OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
132.7Average days
120.5Median days
39Fastest days
236Longest days
1302025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

150 days

AQP4-dependent enhancement of glymphatic function attenuates tau pathology and neurodegeneration in PS19 mice

AuthorsKaoru Yamada; Kazuhisa Ishida; Asami Sakamoto; Hitoshi Shimada; Masaki Watanabe; Masato Shimojo; Hironaka Igarashi; Takeshi Iwatsubo

Affiliations1. Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; 2. Dementia Inclusion and Therapeutics, Graduate School of Medicine, The University of Tokyo Hospital, Tokyo, Japan; 3. Center for Integrated Human Brain Science, Brain Research Institute, Niigata University, Niigata, Japan; 4. Neuroscience Drug Discovery Unit, Takeda Pharmaceutical Co., Ltd. Osaka, Research, Japan; 5. National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan

Source PDF DOI Publisher page
92 days

Passive amyloid-β immunotherapy in Alzheimer’s disease: a multicellular clearance system beyond plaque removal

AuthorsXiaoni Zhan; Chenchen Liu; Changjiang Yu; Nils Lindblom; Tomas Deierborg; Asgeir Kobro-Flatmoen; Gunnar K. Gouras; Gehua Wen

Affiliations1. School of Forensic Medicine, China Medical University, Shenyang, China; 2. Neural Plasticity and Repair Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden; 3. Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 4. Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China; 5. Experimental Dementia Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden; 6. Experimental Neuroinflammation Lab, Department of Experimental Medical Science, Lund University, Lund, Sweden; 7. Kavli Institute for Systems Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway; 8. Norwegian Health Association Centre for Dementia Research, Norwegian University of Science and Technology (NTNU), Postbox, Trondheim, Norway

Source PDF DOI Publisher page
39 days

Breaking the glial loop: astrocytic PAD2 and citrullinated vimentin drive microglial dysfunction in Alzheimer’s disease

AuthorsJeff Y. L. Lam; Guojun Bu

Affiliations1. Division of Life Science and State Key Laboratory of Nervous System Disorders, The Hong Kong University of Science and Technology, Hong Kong, China

Source PDF DOI Publisher page
56 days

A reappraisal of APOE genetic effects on Alzheimer’s disease risk in the Japanese population: a meta-analysis

AuthorsAkinori Miyashita; Norikazu Hara; Ai Obinata; Tamao Tsukie; Mai Hasegawa; Takanobu Ishiguro; Kensaku Kasuga; Masataka Kikuchi; Tadafumi Hashimoto; Takahisa Kanekiyo; Takeshi Ikeuchi

Affiliations1. Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan; 2. Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan; 3. Department of Diagnostic Innovation Science, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan; 4. Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan; 5. Department of Neuroscience, Mayo Clinic, Jacksonville, USA

Source PDF DOI Publisher page
74 days

RAN translation as a dominant pathogenic axis in C9ORF72-associated ALS and FTD models

AuthorsPegah Masrori; Defne Audrey Amado

Affiliations1. Department of Neurology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; 2. Institute of Neuroscience, UCLouvain, Brussels, Belgium; 3. Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA; 4. Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children’s Hospital of Philadelphia, Philadelphia, USA

Source PDF DOI Publisher page
220 days

Tau extent outperforms tau load as a predictor of neurodegeneration in Alzheimer’s disease

AuthorsArthur C. Macedo; Lydia Trudel; Seyyed Ali Hosseini; Joseph Therriault; Étienne Aumont; Gleb Bezgin; Nesrine Rahmouni; Jenna Stevenson; Cécile Tissot; Marcel S. Woo; Stijn Servaes; Stuart Mitchell; Jaime Fernandez-Arias; Brandon Hall; Tevy Chan; Marina Pereira Gonçalves; Pamela C. L. Ferreira; João Pedro Ferrari-Souza; Bruna Bellaver; Firoza Z. Lussier; Andréa L. Benedet; Nicholas J. Ashton; Henrik Zetterberg; Kaj Blennow; Dana L. Tudorascu; Eduardo R. Zimmer; Maxime Montembeault; Jean-Paul Soucy; Jesse Klostranec; Tharick A. Pascoal; Paolo Vitali; Pedro Rosa-Neto

Affiliations1. Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, McConnell Brain Imaging Centre (BIC), Montreal Neurological Institute, Montréal, Canada; 2. Department of Neurology and Neurosurgery, McGill University, Québec, Canada; 3. Montreal Neurological Institute, Québec, Canada; 4. Lawrence Berkeley National Laboratory, Berkeley, USA; 5. Translational Neurodegeneration Laboratory, Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 6. Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, USA; 7. Graduate Program in Biological Sciences: Pharmacology and Therapeutics; and Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; 8. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; 9. Wallenberg Centre for Molecular Medicine, University of Gothenburg, Gothenburg, Sweden; 10. King’s College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, London, UK; 11. NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, UK; 12. Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; 13. Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK; 14. UK Dementia Research Institute at UCL, London, UK; 15. Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China; 16. Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA; 17. Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France; 18. Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, P.R. China; 19. Brain Institute of Rio Grande do Sul, Porto Alegre, Brazil; 20. Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, USA; 21. The Peter O’Donnell Jr. Brain Institute (OBI), University of Texas Southwestern Medical Centre (UTSW), Dallas, USA

Source PDF DOI Publisher page
236 days

Insulin resistance alters cortical inhibitory neurons and microglia to exacerbate Alzheimer’s knock-in mouse phenotypes

AuthorsLaShae Nicholson; Si Jie Tang; Tejaswini Karra; Habiba Abouelatta; Stephen M. Strittmatter

Affiliations1. Departments of Neuroscience and Neurology, Yale School of Medicine, New Haven, USA; 2. Program in Cellular Neuroscience, Neurodegeneration, and Repair, Yale School of Medicine, New Haven, USA; 3. School of Medicine, University of California Davis Medical Center, Sacramento, USA; 4. Institute of Neuropathology, University Medical Centre Göttingen, Göttingen, Germany; 5. Department of Neuroscience and Behavior, Mount Holyoke College, South Hadley, USA

Source PDF DOI Publisher page
219 days

3’UTR regulation of axon translation and optic nerve regeneration

AuthorsMinjuan Bian; Emma L. Huie; Xin Xia; Michael Nahmou; Savana A. Maxfield; Liang Li; Liang Liu; Ziming Luo; Christina Tsien; Katherine J. Healzer; Heather V. Chang; Kristina Russano; Jeffrey L. Goldberg

Affiliations1. Department of Ophthalmology, Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, USA

Source PDF DOI Publisher page
113 days

Cholesterol metabolism in neurodegenerative diseases: mechanisms and therapeutic advances

AuthorsDezhen Tu; Yuxiao Zheng; Pingping Ding; Miao Shen; Wangyang Tang; Bin Wei; Hongyan Wang

Affiliations1. Innovative Institute of Tumor Immunity and Medicine, Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, The First Affiliated Hospital of Anhui Medical University, Hefei, China; 2. State Key Laboratory of Cell Biology & Key Laboratory of RNA Science and Engineering, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China; 3. Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China; 4. Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China

Source PDF DOI Publisher page
128 days

Temporal single-cell atlas of full-length Huntington’s disease mouse model defines stage-specific signatures of corticostriatal dysfunction

AuthorsAshley B. Robbins; Paul T. Ranum; Icnelia Huerta-Ocampo; Michael Kuckyr; Beverly L. Davidson

Affiliations1. Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children’s Hospital of Philadelphia, Philadelphia, USA; 2. Neuroscience Graduate Group, Biomedical Graduate Studies Program, University of Pennsylvania, Philadelphia, USA; 3. Latus Bio, Philadelphia, USA; 4. Cell and Molecular Biology Graduate Group, Biomedical Graduate Studies Program, University of Pennsylvania, Philadelphia, USA; 5. Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.